Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sidney Keisner

Concepts (49)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Bone Density Conservation Agents
2
2023
74
0.870
Why?
Bone Neoplasms
2
2023
178
0.790
Why?
Phenylthiohydantoin
1
2016
2
0.530
Why?
Warfarin
1
2016
82
0.490
Why?
Anticoagulants
1
2016
254
0.430
Why?
Thrombosis
1
2016
250
0.420
Why?
Ketoconazole
1
2010
17
0.350
Why?
Androgen Antagonists
1
2010
11
0.350
Why?
Carcinoma, Renal Cell
1
2011
98
0.340
Why?
Sulfonamides
1
2011
125
0.330
Why?
Proton Pump Inhibitors
1
2010
83
0.330
Why?
Pyrimidines
1
2011
191
0.320
Why?
Kidney Neoplasms
1
2011
171
0.320
Why?
Protein Kinase Inhibitors
1
2011
205
0.320
Why?
Antineoplastic Agents
1
2016
1173
0.290
Why?
Prostatic Neoplasms
1
2010
385
0.270
Why?
Drug Interactions
2
2016
207
0.210
Why?
Phthalazines
1
2022
20
0.190
Why?
Piperazines
1
2022
120
0.180
Why?
Indoles
1
2022
278
0.160
Why?
Retrospective Studies
3
2023
6294
0.140
Why?
Prospective Studies
1
2023
2395
0.140
Why?
Nitriles
1
2016
52
0.130
Why?
Benzamides
1
2016
50
0.130
Why?
Humans
6
2023
50673
0.120
Why?
Male
4
2022
25991
0.110
Why?
Controlled Clinical Trials as Topic
1
2011
22
0.090
Why?
Clinical Trials, Phase III as Topic
1
2011
47
0.090
Why?
Indazoles
1
2011
46
0.090
Why?
Prostate-Specific Antigen
1
2010
44
0.090
Why?
Drug Resistance
1
2010
65
0.090
Why?
Treatment Outcome
2
2011
5294
0.080
Why?
Diphosphonates
1
2011
90
0.080
Why?
Imidazoles
1
2011
128
0.080
Why?
Middle Aged
3
2016
12648
0.080
Why?
Disease-Free Survival
1
2010
442
0.080
Why?
Gastrointestinal Diseases
1
2010
125
0.080
Why?
Drug Therapy, Combination
1
2010
388
0.080
Why?
Acute Kidney Injury
1
2011
302
0.070
Why?
Aged, 80 and over
2
2011
3244
0.060
Why?
Aged
2
2011
9770
0.040
Why?
Animals
1
2011
13156
0.030
Why?
Creatinine
1
2011
142
0.020
Why?
Incidence
1
2011
1036
0.020
Why?
Dose-Response Relationship, Drug
1
2011
1376
0.020
Why?
Time Factors
1
2011
2948
0.010
Why?
Neoplasms
1
2011
1250
0.010
Why?
Adult
1
2011
13636
0.010
Why?
Female
1
2011
27181
0.010
Why?
Keisner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_
Same Department Expand Description